Literature DB >> 2988686

Biochemical studies in paraplegic renal stone patients. 2. Urinary excretion of citrate, inorganic pyrophosphate, silicate and urate.

R G Burr, I Nuseibeh, C D Abiaka.   

Abstract

The urinary excretions of citrate, inorganic orthophosphate and pyrophosphate, silicate and urate were measured in 17 paraplegic patients with renal calculous disease associated with urinary infection, in 16 paraplegics with no history of urinary calculus and in 14 healthy control subjects. The paraplegics excreted less citrate, orthophosphate and pyrophosphate than the control subjects. The stone-formers excreted more urate than the paraplegics without stone disease, but less than the control subjects. There were significant positive correlations between urinary orthophosphate and pyrophosphate and between urinary silicate and 24-h urine volume. The possible roles of increased urate and diminished excretion of citrate and inorganic pyrophosphate in the aetiology of renal calculosis in paraplegic patients deserve further investigation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988686     DOI: 10.1111/j.1464-410x.1985.tb06342.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  The influence of zinc and citrate on urease-induced urine crystallisation.

Authors:  H Hedelin; L Grenabo; J Hugosson; S Pettersson
Journal:  Urol Res       Date:  1989

2.  Percutaneous renal biopsy specimens in stone formers.

Authors:  D J Harrison; J A Inglis; D A Tolley
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

3.  Citrate and urease-induced crystallization in synthetic and human urine.

Authors:  Y H Wang; L Grenabo; H Hedelin; R J McLean; J C Nickel; S Pettersson
Journal:  Urol Res       Date:  1993-03

4.  Intraperitoneal pyrophosphate treatment reduces renal calcifications in Npt2a null mice.

Authors:  Daniel Caballero; Yuwen Li; Jonathan Fetene; Julian Ponsetto; Alyssa Chen; Chuanlong Zhu; Demetrios T Braddock; Clemens Bergwitz
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.